TMT1A and cancer: More exaggeratedly, METTL7A had a high accuracy (AUC > 0.9) in predicting 12 cancer types, including BRCA, COAD, DLBC, LAML, LGG, LUAD, LUSC, OV, READ, STAD, UCEC, and UCS, suggesting that METTL7A may be a very promising molecular indicator for diagnosis.